No Data
Express News | CG Oncology To Present At Society of Urologic Oncology (SUO) 25th Annual Meeting Dec. 4-6
CG Oncology's Financial Results and Clinical Developments
RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $66
Analysts Offer Insights on NA Companies: CG Oncology, Inc. (CGON), Smith Douglas Homes Corp. Class A (SDHC) and Palmer Square Capital BDC Inc. (PSBD)
CG Oncology | 10-Q: Q3 2024 Earnings Report
CG Oncology | 8-K: CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
No Data
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long